In line with our observations, higher resistin levels in women compared to men have been observed previously [35]; however, except for the non-significant associations in postmenopausal women [5], we are not aware of any comparable studies investigating a relationship between higher resistin levels and the risk of CRC stratifying by sex, tumor site, or the combination of sex and tumor site. This evidence concerns the gene RETN and colorectal carcinoma.